OSUR
OraSure Technologies, Inc.
OSUR's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over OSUR overall, supported by stronger modeled upside and lower modeled downside.
OSUR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Strong |
OSUR's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
OSUR PE Valuation
OSUR has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
OSUR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
OSUR has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
OSUR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.70 | +$0.10 |
| Q2 2026 | -$0.70 | -$0.03 |
| Q1 2026 | -$1.05 | -$0.63 |
| Q4 2025 | -$0.94 | -$0.68 |
| Q3 2025 | -$0.80 | -633% |
| Q2 2025 | -$0.67 | -286% |
| Q1 2025 | -$0.42 | -240% |
| Q4 2024 | -$0.26 | -136% |
OSUR lost $0.70 per share over the past year, a smaller loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over OSUR on earnings quality, reporting a profit while its opponent remains loss making.
OSUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30.9M | +14% |
| Q2 2026 | $30.6M | -1.9% |
| Q1 2026 | $27.9M | -6.7% |
| Q4 2025 | $26.8M | -29% |
| Q3 2025 | $27.1M | -32% |
| Q2 2025 | $31.2M | -43% |
| Q1 2025 | $29.9M | -45% |
| Q4 2024 | $37.4M | -51% |
OSUR's revenue is recovering but still below its 2023 peak: $31M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -42% | +18 points |
| Q2 2026 | 18% | +76 points |
| Q1 2026 | -83% | -24 points |
| Q4 2025 | -75% | -42 points |
| Q3 2025 | -59% | -44 points |
| Q2 2025 | -58% | -53 points |
| Q1 2025 | -59% | -46 points |
| Q4 2024 | -33% | -38 points |
OSUR's operating margin was −42% last quarter, up 17 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over OSUR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over OSUR on profitability, with a higher operating margin.
OSUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$12.5M | -$1.6M |
| Q2 2026 | -$12.3M | -$190K |
| Q1 2026 | -$14.8M | +$5.3M |
| Q4 2025 | -$9.9M | -$9.6M |
| Q3 2025 | -$11M | -188% |
| Q2 2025 | -$12.2M | -295% |
| Q1 2025 | -$20.2M | -491% |
| Q4 2024 | -$347K | -101% |
OSUR has burned cash in most quarters: −$50M over the past year, against −$44M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over OSUR on cash generation, producing positive trailing cash flow while its opponent burns cash.
OSUR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -27,857.1x | Net Cash |
| Q2 2024 | -15.0x | Net Cash |
| Q1 2024 | -11.6x | Net Cash |
| Q4 2023 | -5.4x | Net Cash |
| Q3 2023 | -3.4x | Net Cash |
| Q2 2023 | -3.4x | Net Cash |
| Q1 2023 | -2.8x | Net Cash |
| Q4 2021 | -78.2x | Net Cash |
OSUR has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
OSUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 42.0 | Neutral |
OSUR's weekly RSI is 49 (neutral) and its Stochastic is 42 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
OSUR PE vs Healthcare Sector
| Metric | OSUR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
OSUR has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
OSUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.82 | 5.2% below |
| 20 week MA | $3.84 | 5.7% below |
| 50 week MA | $3.38 | 7.1% above |
| 100 week MA | $3.26 | 11% above |
| 200 week MA | $4.43 | 18% below |
OSUR's trend is mixed: it's above two of its five weekly moving averages, and 18% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over OSUR on trend strength, trading above more of its moving averages.
OSUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.92 | $11.6 | +46% |
| 2021 | $11.6 | $9.25 | -20% |
| 2022 | $9.25 | $4.73 | -49% |
| 2023 | $4.73 | $8.20 | +73% |
| 2024 | $8.20 | $3.62 | -56% |
| 2025 | $3.62 | $2.42 | -33% |
| 2026 YTD | $2.42 | $3.62 | +50% |
OSUR has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.